Michelle Goedken, DO
Dermatology · Oro Valley, AZNPI 1609139138
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $46,085 of the $50,474 with a category attached, or 91.3%. Lilly USA, LLC accounts for 78.0% of it on its own, with 22 other manufacturers making up the rest. Reporting peaked in 2021 at $15,655 and has fallen 96.9% since, to $489 in 2025. Among dermatology clinicians in AZ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 230 payments — averaging $219.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$39K
- AbbVie$9K
- Sun Pharmaceutical Industries Inc.$411
- Sanofi$367
- Galderma Laboratories, L.p.$285
- LEO Pharma Inc.$222
- plus $1K from 17 others
What the payments were for
- Speaking & faculty fees$46,08591%
- Travel & lodging$3971%
- Food & beverage$3,9128%
- Education$800%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 72 | $39,359 |
| AbbVie | 43 | $8,635 |
| Sun Pharmaceutical Industries Inc. | 21 | $411 |
| Sanofi | 17 | $367 |
| Galderma Laboratories, L.p. | 12 | $285 |
| LEO Pharma Inc. | 12 | $222 |
| Pfizer | 12 | $201 |
| Novartis | 8 | $165 |
| Amgen | 5 | $121 |
| Organogenesis Inc. | 2 | $113 |
| Nalu Medical, Inc. | 1 | $105 |
| UCB, Inc. | 3 | $86 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 5 | $85 |
| Regeneron Healthcare Solutions, Inc. | 3 | $58 |
| Johnson & Johnson | 3 | $55 |
| EPI Health, LLC | 3 | $49 |
| Incyte Corporation | 2 | $28 |
| Dermavant Sciences, Inc. | 1 | $27 |
| Bioventus LLC | 1 | $26 |
| Dermira, Inc. | 1 | $21 |
| Sanofi-aventis U.S. LLC | 1 | $20 |
| DUSA Pharmaceuticals, Inc. | 1 | $18 |
| VYNE Pharmaceuticals Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TALTZ$38,546
- Rinvoq$7,823
- Nalu Neurostimulation System$105
How this compares
$50,474 in reported general payments places this provider in the 90th percentile of 305 dermatology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 24 | $92,635 |
| Clobetasol Propionate | 48 | $2,136 |
| Ketoconazole | 117 | $1,739 |
| Triamcinolone Acetonide | 132 | $1,624 |
| Doxycycline Hyclate | 59 | $1,131 |
| Metronidazole | 12 | $673 |
| Fluocinonide | 19 | $612 |
| ValacyclovirValacyclovir Hcl | 18 | $304 |
| Hydrocortisone | 50 | $224 |
| Clindamycin Phosphate | 11 | $168 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Oro Valley
- Sheila FarhangOro Valley$153K
- Lindsay AckermanPhoenix$1.6M
- Kathleen ObrienTucson$742K
- Nathalie ZeitouniPhoenix$584K
- John KastelerGilbert$456K
- Anthony NuaraScottsdale$432K
- Carsten HamannPhoenix$364K
- James SlighTucson$238K
- Aaron MangoldScottsdale$171K
- Susan van DykeParadise Valley$164K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.